NeoManna Ltd., a member of the AgChimedes group (www.agchimedes.com), is an animal health company co-founded by AgChimedes and Amir Barzilay. Launched in August 2022, this innovative Agribiotech company develops and commercializes next-generation natural products derived from the circular economy. Their portfolio includes antimicrobial (antibacterial, antifungal, antiviral, and antiparasitic) and anti-inflammatory feed additives for the pet, livestock, and aquaculture industries.

The 1st generation of antimicrobials came from plants. The 2nd generation of antimicrobials is generated from insects and reptiles which lack an adaptive immune system. Black soldier fly (BSF) is outstanding in this microbial-resistant crowd, with long-term evidence in reducing heavy microbial loads in organic wastes by a factor of X1,000,000. NeoManna is utilizing BSF to drive similar impacts on animal health.

NeoManna already developed and contract-manufactures NeoMAG™: a novel anti-microbial portfolio utilizing monoglycerides-enriched BSF oil. NeoMAG™ inclusion rates are just 2% - 5% compared with the inclusion rates of raw unprocessed BSF oil.

This portfolio includes a growth-promoting NeoMAG™ version for pelleted feed and an acute NeoMAG™ version—as an acute antibiotics alternative—for liquid delivery via drinking water and milk replacers. Our focus with NeoMAG™ is on the early production phases: creep feed, pre-starter, and starter.

Controlled studies and field experiments with NeoMAG™ vs. positive “golden standard” controls incorporating phytochemicals in piglets and broilers demonstrate beyond-expected efficacy, safety, and ROI.

NeoManna is also in the advanced phases of commercializing NeoPRO™, a powerful anti-inflammatory portfolio utilizing BSF peptides. In in-vitro experiments, NeoPRO™ is similar or superior to the human steroid Dexamethasone.

All NeoManna products are completely bio-sourced and manufactured in the EU and thus enjoy EU Free Sale Certificates. NeoManna is looking for specialty-focused distributors in the EU and beyond to promote the global expansion of its product sales. NeoManna is currently raising funds through its Series A financing round.